• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从治疗前的(124)I PET/CT成像推断,在甲状腺癌放射性碘治疗期间,咀嚼口香糖刺激并未降低唾液腺的吸收剂量。

Chewing-gum stimulation did not reduce the absorbed dose to salivary glands during radioiodine treatment of thyroid cancer as inferred from pre-therapy (124)I PET/CT imaging.

作者信息

Jentzen Walter, Richter Marion, Nagarajah James, Poeppel Thorsten Dirk, Brandau Wolfgang, Dawes Colin, Bockisch Andreas, Binse Ina

机构信息

Klinik für Nuklearmedizin, Universität Duisburg-Essen, Hufelandstrasse 55, D-45122, Essen, Germany.

Department of Oral Biology, Faculty of Dentistry, University of Manitoba, 780 Bannatyne Avenue, Winnipeg, Manitoba,, R3E 0W2, Canada.

出版信息

EJNMMI Phys. 2014 Dec;1(1):100. doi: 10.1186/s40658-014-0100-1. Epub 2014 Dec 6.

DOI:10.1186/s40658-014-0100-1
PMID:26501458
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4545453/
Abstract

BACKGROUND

The goal of this prospective study was to estimate the absorbed (radiation) doses to salivary glands in radioiodine therapy of thyroid cancer under chewing-gum stimulation using (124)I positron emission tomography (PET)/computed tomography (CT) imaging.

METHODS

Duplex ultrasonography was conducted in three test persons for visual comparison of the glandular blood flow with three different stimulation types (no stimulation, chewing tasteless gum base, sucking on lemon slices). Ten patients with newly diagnosed differentiated thyroid cancer received (124)I PET/CT dosimetry after thyroidectomy and prior to radioiodine therapy. Patients underwent a series of three (124)I PET/CT scans (4, 24, and ≥96 h after administration of 23 MBq (124)I). They were instructed to chew gum base (tasteless) approximately 20 min after ingesting the (124)I-containing capsule in the course of the first day. Absorbed doses per administered (131)I activity to the salivary glands were calculated and compared with the previously published results of the lemon-juice stimulation and non-stimulation groups.

RESULTS

The sonograms in the three test persons showed that glandular blood perfusion by lemon-juice stimulation was clearly increased compared with non-stimulation or chewing of gum base. The sonogram comparison between the chewing-gum stimulation and non-stimulation demonstrated a minor increase of blood flow for the gum base-stimulated salivary glands. The mean ± standard deviation of the absorbed dose per activity under chewing-gum stimulation for the submandibular and parotid glands (within parentheses) was 0.22 ± 0.09 Gy/GBq (0.22 ± 0.08 Gy/GBq). Compared with the absorbed doses of the non-stimulation group, 0.24 ± 0.08 Gy/GBq (0.21 ± 0.05 Gy/GBq), those of the chewing-gum stimulation group showed no significant change (P > 0.60), but the absorbed doses of the lemon-juice stimulation group, 0.35 ± 0.14 Gy/GBq (0.33 ± 0.09 Gy/GBq), were significantly higher (P < 0.04) than those of the chewing-gum stimulation group.

CONCLUSIONS

The results suggest that salivary flow induced by chewing gum base does not cause a significant reduction of the salivary gland absorbed dose compared with that in the non-stimulation group. The increased blood flow appears to be a decisive factor causing the increased (131)I absorbed doses in the lemon-juice stimulation group.

摘要

背景

本前瞻性研究的目的是利用(124)I 正电子发射断层扫描(PET)/计算机断层扫描(CT)成像,估算在口香糖刺激下甲状腺癌放射性碘治疗中唾液腺的吸收(辐射)剂量。

方法

对三名受试者进行双功超声检查,以视觉比较三种不同刺激类型(无刺激、咀嚼无味口香糖基、吮吸柠檬片)下的腺体血流情况。十名新诊断为分化型甲状腺癌的患者在甲状腺切除术后及放射性碘治疗前接受了(124)I PET/CT 剂量测定。患者在给予 23 MBq(124)I 后进行了一系列三次(124)I PET/CT 扫描(给药后 4、24 和≥96 小时)。在第一天服用含(124)I 胶囊后约 20 分钟,指导他们咀嚼口香糖基(无味)。计算每给予的(131)I 活度对唾液腺的吸收剂量,并与先前发表的柠檬汁刺激组和无刺激组的结果进行比较。

结果

三名受试者的超声图显示,与无刺激或咀嚼口香糖基相比,柠檬汁刺激下的腺体血流灌注明显增加。口香糖刺激组与无刺激组的超声图比较显示,口香糖基刺激的唾液腺血流略有增加。在口香糖刺激下,下颌下腺和腮腺(括号内)每活度吸收剂量的平均值±标准差为 0.22±0.09 Gy/GBq(0.22±0.08 Gy/GBq)。与无刺激组的吸收剂量 0.24±0.08 Gy/GBq(0.21±0.05 Gy/GBq)相比,口香糖刺激组的吸收剂量无显著变化(P>0.60),但柠檬汁刺激组的吸收剂量 0.35±0.14 Gy/GBq(0.33±0.09 Gy/GBq)显著高于口香糖刺激组(P<0.04)。

结论

结果表明,与无刺激组相比,咀嚼口香糖基引起的唾液流动不会导致唾液腺吸收剂量显著降低。血流增加似乎是导致柠檬汁刺激组(131)I 吸收剂量增加的决定性因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45e4/4545453/5a6bbf7b4045/40658_2014_100_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45e4/4545453/9e2e472aae0b/40658_2014_100_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45e4/4545453/17a5103a64cc/40658_2014_100_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45e4/4545453/7d384938c311/40658_2014_100_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45e4/4545453/5a6bbf7b4045/40658_2014_100_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45e4/4545453/9e2e472aae0b/40658_2014_100_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45e4/4545453/17a5103a64cc/40658_2014_100_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45e4/4545453/7d384938c311/40658_2014_100_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45e4/4545453/5a6bbf7b4045/40658_2014_100_Fig4_HTML.jpg

相似文献

1
Chewing-gum stimulation did not reduce the absorbed dose to salivary glands during radioiodine treatment of thyroid cancer as inferred from pre-therapy (124)I PET/CT imaging.从治疗前的(124)I PET/CT成像推断,在甲状腺癌放射性碘治疗期间,咀嚼口香糖刺激并未降低唾液腺的吸收剂量。
EJNMMI Phys. 2014 Dec;1(1):100. doi: 10.1186/s40658-014-0100-1. Epub 2014 Dec 6.
2
The influence of saliva flow stimulation on the absorbed radiation dose to the salivary glands during radioiodine therapy of thyroid cancer using 124I PET(/CT) imaging.124I PET(/CT) 成像引导下甲状腺癌放射性碘治疗中唾液流量刺激对唾液腺吸收剂量的影响。
Eur J Nucl Med Mol Imaging. 2010 Dec;37(12):2298-306. doi: 10.1007/s00259-010-1532-z. Epub 2010 Jul 13.
3
Discrepant salivary gland response after radioiodine and MIBG therapies.放射性碘和间碘苄胍治疗后唾液腺反应的差异。
Q J Nucl Med Mol Imaging. 2017 Sep;61(3):331-339. doi: 10.23736/S1824-4785.17.02760-1. Epub 2015 Jan 8.
4
Pre-therapeutic (124)I PET(/CT) dosimetry confirms low average absorbed doses per administered (131)I activity to the salivary glands in radioiodine therapy of differentiated thyroid cancer.治疗前(124)I PET(/CT) 剂量学证实,分化型甲状腺癌放射性碘治疗中,每给予(131)I 活度的唾液腺平均吸收剂量较低。
Eur J Nucl Med Mol Imaging. 2010 May;37(5):884-95. doi: 10.1007/s00259-009-1351-2. Epub 2010 Jan 13.
5
Relationship between cumulative radiation dose and salivary gland uptake associated with radioiodine therapy of thyroid cancer.甲状腺癌放射性碘治疗中累积辐射剂量与唾液腺摄取之间的关系。
Nucl Med Commun. 2006 Aug;27(8):669-76. doi: 10.1097/00006231-200608000-00009.
6
SPECT/CT-based dosimetry of salivary glands and iodine-avid lesions following I therapy.基于SPECT/CT的I治疗后唾液腺及碘摄取性病变的剂量测定
Health Technol (Berl). 2023;13(1):101-110. doi: 10.1007/s12553-022-00718-y. Epub 2023 Jan 6.
7
Iodine kinetics and dosimetry in the salivary glands during repeated courses of radioiodine therapy for thyroid cancer.甲状腺癌重复放射性碘治疗期间唾液腺中的碘动力学和剂量学。
Med Phys. 2011 Oct;38(10):5412-9. doi: 10.1118/1.3602459.
8
Does lemon candy decrease salivary gland damage after radioiodine therapy for thyroid cancer?柠檬糖能否降低甲状腺癌放射性碘治疗后的唾液腺损伤?
J Nucl Med. 2005 Feb;46(2):261-6.
9
Salivary gland protection with sialagogues: a case study.使用催涎剂保护唾液腺:一项病例研究。
Thyroid. 2009 Sep;19(9):1005-8. doi: 10.1089/thy.2008.0381.
10
The effect of chewing-gum on dose rate of salivary gland in differentiated thyroid carcinoma patients treated with radioiodine.口香糖对放射性碘治疗分化型甲状腺癌患者唾液腺剂量率的影响。
Q J Nucl Med Mol Imaging. 2020 Sep;64(3):321-325. doi: 10.23736/S1824-4785.18.03078-9. Epub 2018 Apr 26.

引用本文的文献

1
Optimal administration time of vitamin C after I therapy in differentiated thyroid cancer based on propensity score matching.基于倾向得分匹配的分化型甲状腺癌碘治疗后维生素C的最佳给药时间
Front Surg. 2022 Sep 22;9:993712. doi: 10.3389/fsurg.2022.993712. eCollection 2022.
2
Efficiency of I radioisotope production from natural and enriched tellurium dioxide using Te(p,xn)I reaction.利用Te(p,xn)I反应从天然和富集二氧化碲生产碘放射性同位素的效率。
EJNMMI Phys. 2022 Jun 6;9(1):41. doi: 10.1186/s40658-022-00471-1.
3
The effect of eating on the uptake of PSMA ligands in the salivary glands.

本文引用的文献

1
Radioprotective agents for the prevention of side effects induced by radioiodine-131 therapy.用于预防放射性碘 131 治疗引起的副作用的放射防护剂。
Future Oncol. 2013 Aug;9(8):1145-59. doi: 10.2217/fon.13.79.
2
Monte Carlo-based 3-dimensional dosimetry of salivary glands in radioiodine treatment of differentiated thyroid cancer estimated using 124I PET.基于蒙特卡洛方法,利用124I正电子发射断层显像(PET)对分化型甲状腺癌放射性碘治疗中唾液腺进行三维剂量测定。
Q J Nucl Med Mol Imaging. 2013 Mar;57(1):79-91.
3
Modulation of sodium/iodide symporter expression in the salivary gland.
进食对唾液腺中PSMA配体摄取的影响。
EJNMMI Res. 2021 Sep 26;11(1):95. doi: 10.1186/s13550-021-00838-y.
4
Sialadenitis as a complication of radioiodine therapy in patients with thyroid cancer: where do we stand?涎腺炎作为甲状腺癌患者放射性碘治疗的并发症:我们目前的情况如何?
Hormones (Athens). 2021 Dec;20(4):669-678. doi: 10.1007/s42000-021-00304-3. Epub 2021 Jun 18.
5
Early Quantification of Salivary Gland Function after Radioiodine Therapy.放射性碘治疗后唾液腺功能的早期量化
Indian J Nucl Med. 2021 Jan-Mar;36(1):25-31. doi: 10.4103/ijnm.IJNM_158_20. Epub 2021 Mar 4.
6
Scintigraphic evaluation of salivary gland function in thyroid cancer patients after radioiodine remnant ablation.放射性碘残留消融术后甲状腺癌患者唾液腺功能的闪烁显像评估
Eur J Oral Sci. 2020 Jun;128(3):204-210. doi: 10.1111/eos.12689. Epub 2020 Apr 2.
7
Radioactive iodine: An unappreciated threat to salivary gland function.放射性碘:唾液腺功能的一个未被重视的威胁。
Oral Dis. 2018 Mar;24(1-2):198-201. doi: 10.1111/odi.12774.
8
Seeking Optimal Management for Radioactive Iodine Therapy-induced Adverse Effects.寻求放射性碘治疗所致不良反应的最佳管理方法。
Asia Pac J Oncol Nurs. 2017 Oct-Dec;4(4):319-322. doi: 10.4103/apjon.apjon_23_17.
9
Clinical Studies of Nonpharmacological Methods to Minimize Salivary Gland Damage after Radioiodine Therapy of Differentiated Thyroid Carcinoma: Systematic Review.分化型甲状腺癌放射性碘治疗后减少唾液腺损伤的非药物方法的临床研究:系统评价
Evid Based Complement Alternat Med. 2016;2016:6795076. doi: 10.1155/2016/6795076. Epub 2016 Jun 30.
调控唾液腺中钠/碘同向转运体的表达。
Thyroid. 2013 Aug;23(8):1029-36. doi: 10.1089/thy.2012.0571. Epub 2013 Jul 17.
4
Complications of radioactive iodine treatment of thyroid carcinoma.甲状腺癌放射性碘治疗的并发症。
J Natl Compr Canc Netw. 2010 Nov;8(11):1277-86; quiz 1287. doi: 10.6004/jnccn.2010.0094.
5
Radiopharmacokinetics of radioiodine in the parotid glands after the administration of lemon juice.柠檬汁给药后腮腺中放射性碘的放射性药物动力学。
Thyroid. 2010 Oct;20(10):1113-9. doi: 10.1089/thy.2009.0429.
6
The influence of saliva flow stimulation on the absorbed radiation dose to the salivary glands during radioiodine therapy of thyroid cancer using 124I PET(/CT) imaging.124I PET(/CT) 成像引导下甲状腺癌放射性碘治疗中唾液流量刺激对唾液腺吸收剂量的影响。
Eur J Nucl Med Mol Imaging. 2010 Dec;37(12):2298-306. doi: 10.1007/s00259-010-1532-z. Epub 2010 Jul 13.
7
Influence of vitamin C on salivary absorbed dose of 131I in thyroid cancer patients: a prospective, randomized, single-blind, controlled trial.维生素 C 对甲状腺癌患者唾液 131I 吸收剂量的影响:一项前瞻性、随机、单盲、对照试验。
J Nucl Med. 2010 Apr;51(4):618-23. doi: 10.2967/jnumed.109.071449. Epub 2010 Mar 17.
8
Pre-therapeutic (124)I PET(/CT) dosimetry confirms low average absorbed doses per administered (131)I activity to the salivary glands in radioiodine therapy of differentiated thyroid cancer.治疗前(124)I PET(/CT) 剂量学证实,分化型甲状腺癌放射性碘治疗中,每给予(131)I 活度的唾液腺平均吸收剂量较低。
Eur J Nucl Med Mol Imaging. 2010 May;37(5):884-95. doi: 10.1007/s00259-009-1351-2. Epub 2010 Jan 13.
9
Salivary gland protection with sialagogues: a case study.使用催涎剂保护唾液腺:一项病例研究。
Thyroid. 2009 Sep;19(9):1005-8. doi: 10.1089/thy.2008.0381.
10
Guidelines for radioiodine therapy of differentiated thyroid cancer.分化型甲状腺癌放射性碘治疗指南。
Eur J Nucl Med Mol Imaging. 2008 Oct;35(10):1941-59. doi: 10.1007/s00259-008-0883-1.